Anand Vijay, Bates Angela, Featherstone Robin, Murthy Srinivas
University of Alberta, Edmonton, Canada.
University of Pennsylvania, Philadelphia, USA.
Syst Rev. 2017 May 30;6(1):107. doi: 10.1186/s13643-017-0502-y.
Post-operative infections in pediatric cardiac surgery are an ongoing clinical challenge, with rates between 1 and 20%. Perioperative antibiotics remain the standard for prevention of surgical-site infections, but the type of antibiotic and duration of administration remain poorly defined. Current levels of practice variation through informal surveys are very high. Rates of antibiotic-resistant organisms are increasing steadily around the world.
METHODS/DESIGN: We will identify all controlled observational studies and randomized controlled trials examining prophylactic antibiotic use in pediatric cardiac surgery. Data sources will include MEDLINE, EMBASE, CENTRAL, and proceedings from recent relevant scientific meetings. For each included study, we will conduct duplicate independent data extraction, risk of bias assessment, and evaluation of quality of evidence using the GRADE approach.
We will report the results of this review in agreement with the PRISMA statement and disseminate our findings at relevant critical care and cardiology conferences and through publication in peer-reviewed journals. We will use this systematic review to inform clinical guidelines, which will be disseminated in a separate stand-alone publication.
PROSPERO CRD42016052978C.
小儿心脏手术术后感染仍是一个持续存在的临床挑战,感染率在1%至20%之间。围手术期使用抗生素仍然是预防手术部位感染的标准方法,但抗生素的类型和给药持续时间仍不明确。通过非正式调查得出的当前实践差异水平非常高。世界各地抗生素耐药菌的发生率正在稳步上升。
方法/设计:我们将识别所有关于小儿心脏手术预防性使用抗生素的对照观察性研究和随机对照试验。数据来源将包括MEDLINE、EMBASE、CENTRAL以及近期相关科学会议的论文集。对于每项纳入研究,我们将进行重复的独立数据提取、偏倚风险评估,并使用GRADE方法评估证据质量。
我们将按照PRISMA声明报告本综述的结果,并在相关的重症监护和心脏病学会议上公布我们的研究结果,同时通过在同行评审期刊上发表。我们将利用这一系统综述为临床指南提供信息,该指南将在一份单独的独立出版物中发布。
PROSPERO CRD42016052978C。